Jazz Pharmaceuticals plc
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $1.74B | $1.98B | $347.0M |
| Jun 2017 | $1.64B | $2.20B | $239.2M |
| Sep 2017 | $1.54B | $2.47B | $252.6M |
| Dec 2017 | $1.54B | $2.71B | $386.0M |
| Mar 2018 | $1.54B | $2.79B | $453.2M |
| Jun 2018 | $1.56B | $2.87B | $485.1M |
| Sep 2018 | $1.56B | $3.03B | $499.0M |
| Dec 2018 | $1.56B | $2.76B | $309.6M |
| Mar 2019 | $1.57B | $2.73B | $547.5M |
| Jun 2019 | $1.57B | $2.98B | $637.7M |
| Sep 2019 | $1.57B | $3.05B | $795.2M |
| Dec 2019 | $1.57B | $3.11B | $637.3M |
| Mar 2020 | $1.58B | $2.81B | $701.6M |
| Jun 2020 | $2.07B | $3.14B | $786.1M |
| Sep 2020 | $1.84B | $3.38B | $741.9M |
| Dec 2020 | $1.85B | $3.66B | $1.06B |
| Mar 2021 | $1.85B | $3.80B | $2.10B |
| Jun 2021 | $6.49B | $4.13B | $891.4M |
| Sep 2021 | $6.25B | $3.94B | $671.8M |
| Dec 2021 | $6.02B | $3.97B | $591.4M |
| Mar 2022 | $5.99B | $3.61B | $490.8M |
| Jun 2022 | $5.99B | $3.20B | $711.3M |
| Sep 2022 | $5.70B | $2.75B | $839.4M |
| Dec 2022 | $5.69B | $3.09B | $881.5M |
| Mar 2023 | $5.69B | $3.34B | $1.17B |
| Jun 2023 | $5.69B | $3.53B | $1.28B |
| Sep 2023 | $5.11B | $3.49B | $1.34B |
| Dec 2023 | $5.11B | $3.74B | $1.51B |
| Mar 2024 | $5.11B | $3.70B | $1.44B |
| Jun 2024 | $5.10B | $3.76B | $1.36B |
| Sep 2024 | $6.08B | $4.17B | $2.22B |
| Dec 2024 | $6.08B | $4.09B | $2.41B |
| Mar 2025 | $5.34B | $4.17B | $1.86B |
| Jun 2025 | $4.34B | $3.71B | $1.19B |
| Sep 2025 | $4.33B | $3.96B | $1.33B |
| Dec 2025 | $4.33B | $4.32B | $1.39B |
| Mar 2026 | $4.32B | $4.53B | $1.84B |
| Jun 2026 | $3.34B | $4.80B | $1.62B |